Alphacentric Lifesci Healthcare Fund Manager Performance Evaluation

LYFIX Fund  USD 13.77  0.03  0.22%   
The fund shows a Beta (market volatility) of 0.61, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Alphacentric Lifesci's returns are expected to increase less than the market. However, during the bear market, the loss of holding Alphacentric Lifesci is expected to be smaller as well.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alphacentric Lifesci Healthcare has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Alphacentric Lifesci is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
...more
1
Un-Gala A Night of Lyrics Laughter - NOW Toronto
09/13/2024
Expense Ratio Date1st of August 2022
Expense Ratio1.4100
  

Alphacentric Lifesci Relative Risk vs. Return Landscape

If you would invest  1,400  in Alphacentric Lifesci Healthcare on September 5, 2024 and sell it today you would lose (23.00) from holding Alphacentric Lifesci Healthcare or give up 1.64% of portfolio value over 90 days. Alphacentric Lifesci Healthcare is currently producing negative expected returns and takes up 0.7974% volatility of returns over 90 trading days. Put another way, 7% of traded mutual funds are less volatile than Alphacentric, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Alphacentric Lifesci is expected to under-perform the market. In addition to that, the company is 1.07 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.21 per unit of volatility.

Alphacentric Lifesci Current Valuation

Fairly Valued
Today
13.77
Please note that Alphacentric Lifesci's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Alphacentric Lifesci shows a prevailing Real Value of $13.76 per share. The current price of the fund is $13.77. We determine the value of Alphacentric Lifesci from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Alphacentric Lifesci is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alphacentric Mutual Fund. However, Alphacentric Lifesci's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  13.77 Real  13.76 Hype  13.77 Naive  14.26
The intrinsic value of Alphacentric Lifesci's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alphacentric Lifesci's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
13.76
Real Value
14.56
Upside
Estimating the potential upside or downside of Alphacentric Lifesci Healthcare helps investors to forecast how Alphacentric mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alphacentric Lifesci more accurately as focusing exclusively on Alphacentric Lifesci's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
13.4813.7013.92
Details
Hype
Prediction
LowEstimatedHigh
12.9713.7714.57
Details
Naive
Forecast
LowNext ValueHigh
13.4714.2615.06
Details

Alphacentric Lifesci Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Alphacentric Lifesci's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Alphacentric Lifesci Healthcare, and traders can use it to determine the average amount a Alphacentric Lifesci's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0285

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsLYFIX

Estimated Market Risk

 0.8
  actual daily
7
93% of assets are more volatile

Expected Return

 -0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Alphacentric Lifesci is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alphacentric Lifesci by adding Alphacentric Lifesci to a well-diversified portfolio.

Alphacentric Lifesci Fundamentals Growth

Alphacentric Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Alphacentric Lifesci, and Alphacentric Lifesci fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alphacentric Mutual Fund performance.

About Alphacentric Lifesci Performance

Evaluating Alphacentric Lifesci's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Alphacentric Lifesci has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Alphacentric Lifesci has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Under normal market conditions, the fund invests at least 80 percent of its net assets plus borrowings for investment purposes in the securities of companies in the life sciences and healthcare sectors, which the managers define to be the category of companies related to producing or supplying facilities, supplies, technology, pharmaceuticals, equipment, devices or services for the preservation and care of a persons or animals health.

Things to note about Alphacentric Lifesci performance evaluation

Checking the ongoing alerts about Alphacentric Lifesci for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Alphacentric Lifesci help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Alphacentric Lifesci generated a negative expected return over the last 90 days
The fund maintains about 5.9% of its assets in cash
Evaluating Alphacentric Lifesci's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Alphacentric Lifesci's mutual fund performance include:
  • Analyzing Alphacentric Lifesci's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alphacentric Lifesci's stock is overvalued or undervalued compared to its peers.
  • Examining Alphacentric Lifesci's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Alphacentric Lifesci's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alphacentric Lifesci's management team can help you assess the Mutual Fund's leadership.
  • Pay attention to analyst opinions and ratings of Alphacentric Lifesci's mutual fund. These opinions can provide insight into Alphacentric Lifesci's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Alphacentric Lifesci's mutual fund performance is not an exact science, and many factors can impact Alphacentric Lifesci's mutual fund market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Alphacentric Mutual Fund

Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account